Urinary biomarkers in relapsing antineutrophil cytoplasmic antibody-associated vasculitis

Journal of Rheumatology

Volumn 40, Issue 5, 2013, Pages 674-683

  Lieberthal, Jason G ^a   Cuthbertson, David ^b   Carette, Simon ^c   Hoffman, Gary S ^d   Khalidi, Nader A ^e   Koening, Curry L ^f   Langford, Carol A ^d   Maksimowicz McKinnon, Kathleen ^g   Seo, Philip ^h   Specks, Ulrich ⁱ   Ytterberg, Steven R ⁱ   Merkel, Peter A ^j   Monach, Paul A ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c MOUNT SINAI HOSPITAL   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e MCMASTER UNIVERSITY   (Canada)

^f UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^h JOHNS HOPKINS UNIVERSITY   (United States)

ⁱ Mayo Clinic   (United States)

^j UNIVERSITY OF PENNSYLVANIA   (United States)

more..

Author keywords

Biomarkers; Glomerulonephritis; Monocyte chemoattractant protein 1; Vasculitis; Wegener granulomatosis

Indexed keywords

BIOLOGICAL MARKER; CREATININE; KIDNEY INJURY MOLECULE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; OROSOMUCOID;

ADULT; AGED; ANCA ASSOCIATED VASCULITIS; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE URINE LEVEL; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE EXACERBATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH STATUS; HEMATURIA; HUMAN; INTERMETHOD COMPARISON; KIDNEY DISEASE; LONGITUDINAL STUDY; MALE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RELAPSE; REMISSION; SENSITIVITY AND SPECIFICITY; URINALYSIS; URINE LEVEL;

BIOMARKERS; GLOMERULONEPHRITIS; MONOCYTE CHEMOATTRACTANT PROTEIN-1; VASCULITIS; WEGENER GRANULOMATOSIS;

ACUTE-PHASE PROTEINS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; BIOLOGICAL MARKERS; CHEMOKINE CCL2; FEMALE; GLOMERULONEPHRITIS; HUMANS; LIPOCALINS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; OROSOMUCOID; PREDICTIVE VALUE OF TESTS; PROTO-ONCOGENE PROTEINS; RECEPTORS, VIRUS; RECURRENCE; ROC CURVE; TIME FACTORS; YOUNG ADULT;

EID: 84876945304     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.120879     Document Type: Article

References (44)

1. Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992;116:488-98.
2. Reinhold-Keller E, Beuge N, Latza U, de Groot K, Rudert H, Nolle B, et al. An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients. Arthritis Rheum 2000;43:1021-32. (Pubitemid 30368179)
3. Pagnoux C, Hogan SL, Chin H, Jennette JC, Falk RJ, Guillevin L, et al. Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis: comparison of two independent cohorts. Arthritis Rheum 2008;58:2908-18.
4. Booth AD, Almond MK, Burns A, Ellis P, Gaskin G, Neild GH, et al. Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study. Am J Kidney Dis 2003;41:776-84. (Pubitemid 36396745)
5. Guillevin L, Cohen P, Gayraud M, Lhote F, Jarrousse B, Casassus P. Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Medicine 1999;78:26-37. (Pubitemid 29065978)
6. Solans R, Bosch JA, Perez-Bocanegra C, Selva A, Huguet P, Alijotas J, et al. Churg-Strauss syndrome: outcome and long-term follow-up of 32 patients. Rheumatology 2001;40:763-71.
7. Della Rossa A, Baldini C, Tavoni A, Tognetti A, Neglia D, Sambuceti G, et al. Churg-Strauss syndrome: clinical and serological features of 19 patients from a single Italian centre. Rheumatology 2002;41:1286-94. (Pubitemid 35363804)
8. Dunogue B, Pagnoux C, Guillevin L. Churg-strauss syndrome: clinical symptoms, complementary investigations, prognosis and outcome, and treatment. Semin Respir Crit Care Med 2011;32:298-309.
9. Nguyen MT, Devarajan P. Biomarkers for the early detection of acute kidney injury. Pediatr Nephrol 2008;23:2151-7.
10. Magrey MN, Villa-Forte A, Koening CL, Myles JL, Hoffman GS. Persistent hematuria after induction of remission in Wegener granulomatosis: a therapeutic dilemma. Medicine 2009;88:315-21.
11. Pisitkun T, Johnstone R, Knepper MA. Discovery of urinary biomarkers. Mol Cell Proteomics 2006;5:1760-71. (Pubitemid 44688186)
12. Mosley K, Tam FW, Edwards RJ, Crozier J, Pusey CD, Lightstone L. Urinary proteomic profiles distinguish between active and inactive lupus nephritis. Rheumatology 2006;45:1497-504. (Pubitemid 44817055)
13. Suzuki M, Wiers K, Brooks EB, Greis KD, Haines K, Klein-Gitelman MS, et al. Initial validation of a novel protein biomarker panel for active pediatric lupus nephritis. Pediatr Res 2009;65:530-6.
14. Tam FW, Sanders JS, George A, Hammad T, Miller C, Dougan T, et al. Urinary monocyte chemoattractant protein-1 (MCP-1) is a marker of active renal vasculitis. Nephrol Dial Transplant 2004;19:2761-8. (Pubitemid 39480970)
15. Tesar V, Masek Z, Rychlik I, Merta M, Bartunkova J, Stejskalova A, et al. Cytokines and adhesion molecules in renal vasculitis and lupus nephritis. Nephrol Dial Transplant 1998;13:1662-7. (Pubitemid 28306791)
16. Sanders JS, Huitema MG, Hanemaaijer R, van Goor H, Kallenberg CG, Stegeman CA. Urinary matrix metalloproteinases reflect renal damage in anti-neutrophil cytoplasm autoantibody-associated vasculitis. Am J Physiol Renal Physiol 2007;293:F1927-34. (Pubitemid 350179617)
17. Ohlsson S, Bakoush O, Tencer J, Torffvit O, Segelmark M. Monocyte chemoattractant protein 1 is a prognostic marker in ANCA-associated small vessel vasculitis. Mediators Inflamm 2009;2009:584916.
18. Ichimura T, Bonventre JV, Bailly V, Wei H, Hession CA, Cate RL, et al. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem 1998;273:4135-42. (Pubitemid 28103282)
19. Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV. Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Kidney Int 2002;62:237-44. (Pubitemid 34754067)
20. Ichimura T, Hung CC, Yang SA, Stevens JL, Bonventre JV. Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury. Am J Physiol Renal Physiol 2004;286:F552-63. (Pubitemid 38233650)
21. Vaidya VS, Ramirez V, Ichimura T, Bobadilla NA, Bonventre JV. Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. Am J Physiol Renal Physiol 2006;290:F517-29. (Pubitemid 43725006)
22. Waanders F, van Timmeren MM, Stegeman CA, Bakker SJ, van Goor H. Kidney injury molecule-1 in renal disease. J Pathol 2010;220:7-16.
23. van Timmeren MM, van den Heuvel MC, Bailly V, Bakker SJ, van Goor H, Stegeman CA. Tubular kidney injury molecule-1 (KIM-1) in human renal disease. J Pathol 2007;212:209-17. (Pubitemid 46852099)
24. Kjeldsen L, Johnsen AH, Sengelov H, Borregaard N. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem 1993;268:10425-32. (Pubitemid 23150227)
25. Mishra J, Ma Q, Prada A, Mitsnefes M, Zahedi K, Yang J, et al. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 2003;14:2534-43. (Pubitemid 37169339)
26. Mori K, Nakao K. Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damage. Kidney Int 2007;71:967-70. (Pubitemid 46741985)
27. Pitashny M, Schwartz N, Qing X, Hojaili B, Aranow C, Mackay M, et al. Urinary lipocalin-2 is associated with renal disease activity in human lupus nephritis. Arthritis Rheum 2007;56:1894-903. (Pubitemid 47110388)
28. Rubinstein T, Pitashny M, Levine B, Schwartz N, Schwartzman J, Weinstein E, et al. Urinary neutrophil gelatinase-associated lipocalin as a novel biomarker for disease activity in lupus nephritis. Rheumatology 2010;49:960-71.
29. Boring L, Gosling J, Chensue SW, Kunkel SL, Farese RV, Jr, Broxmeyer HE, et al. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin Invest 1997;100:2552-61. (Pubitemid 27514895)
30. Rovin BH, Rumancik M, Tan L, Dickerson J. Glomerular expression of monocyte chemoattractant protein-1 in experimental and human glomerulonephritis. Lab Invest 1994;71:536-42. (Pubitemid 24338161)
31. Tesch GH. MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy. Am J Physiol Renal Physiol 2008;294:F697-701.
32. Rovin BH, Song H, Birmingham DJ, Hebert LA, Yu CY, Nagaraja HN. Urine chemokines as biomarkers of human systemic lupus erythematosus activity. J Am Soc Nephrol 2005;16:467-73. (Pubitemid 41725143)
33. Suzuki M, Ross GF, Wiers K, Nelson S, Bennett M, Passo MH, et al. Identification of a urinary proteomic signature for lupus nephritis in children. Pediatr Nephrol 2007;22:2047-57. (Pubitemid 350090711)
34. Stone JH, Hoffman GS, Merkel PA, Min YI, Uhlfelder ML, Hellmann DB, et al. A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS). Arthritis Rheum 2001;44:912-20. (Pubitemid 32319784)
35. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006;145:247-54. (Pubitemid 46768608)
36. Fraser CG. Biological variation: from principles to practice. Washington, DC: AACC Press; 2001.
37. Harris EK. Effects of intra- and interindividual variation on the appropriate use of normal ranges. Clin Chem 1974;20:1535-42.
38. Youden WJ. Index for rating diagnostic tests. Cancer 1950;3:32-5.
39. Petersen PH, Fraser CG, Sandberg S, Goldschmidt H. The index of individuality is often a misinterpreted quantity characteristic. Clin Chem Lab Med 1999;37:655-61. (Pubitemid 29396809)
40. Petersen PH, Sandberg S, Fraser CG, Goldschmidt H. Influence of index of individuality on false positives in repeated sampling from healthy individuals. Clin Chem Lab Med 2001;39:160-5. (Pubitemid 32318481)
41. Kim MJ, Tam FW. Urinary monocyte chemoattractant protein-1 in renal disease. Clin Chim Acta 2011;412:2022-30.
42. Tomasson G, Lavalley M, Tanriverdi K, Finkielman JD, Davis JC Jr, Hoffman GS, et al. Relationship between markers of platelet activation and inflammation with disease activity in Wegener's granulomatosis. J Rheumatol 2011;38:1048-54.
43. Wada T, Furuichi K, Segawa-Takaeda C, Shimizu M, Sakai N, Takeda SI, et al. MIP-1-alpha and MCP-1 contribute to crescents and interstitial lesions in human crescentic glomerulonephritis. Kidney Int 1999;56:995-1003. (Pubitemid 29411726)
44. Petersen PH, Fraser CG, Kallner A, Kenny D, editors. Strategies to set global quality specifications in laboratory medicine. Scand J Clin Lab Invest 1999;59:475-585.